Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein

Endocrinology

Volumn 151, Issue 8, 2010, Pages 3566-3576

  Wu, Ke ^a,c   Cappel, David ^b   Martinez, Melissa ^b   Stafford, John M ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; SOMATOSTATIN; TRANSCRIPTION FACTOR FKHR; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOINSULINEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL NUCLEUS; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; INSULIN; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; MALE; NERVE TISSUE PROTEINS; RATS; RATS, LONG-EVANS; RATS, TRANSGENIC; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 77954925939     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0204     Document Type: Article

References (48)

1. Adiels M, Borén J, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Packard C, Taskinen MR 2005 Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 25:1697-1703
2. Bernstein RM, Davis BM, Olefsky JM, Reaven GM 1978 Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia. Diabetologia 14:249-253 (Pubitemid 8300429)
3. Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ 2004 Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middleaged subjects. Atherosclerosis 176:49-56 (Pubitemid 39078644)
4. Kissebah AH, Alfarsi S, Adams PW, Wynn V 1976 Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12:563-571
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP 1992 Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722
6. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653 (Pubitemid 41817713)
7. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G 1995 Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166
8. Rashid S, Watanabe T, Sakaue T, Lewis GF 2003 Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem 36:421-429 (Pubitemid 37083556)
9. Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, Lewis GF 1999 Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 103:1191-1199 (Pubitemid 29207253)
10. Jackson TK, Salhanick AI, Elovson J, Deichman ML, Amatruda JM 1990 Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J Clin Invest 86:1746-1751
11. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J 1989 The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065-1077
12. Malmström R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR 1997 Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1464
13. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH 2008 FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 118:2347-2364
14. Matsumoto M, Han S, Kitamura T, Accili D 2006 Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464-2472
15. Mitchell DM, Zhou M, Pariyarath R, Wang H, Aitchison JD, Ginsberg HN, Fisher EA 1998 A poprotein B100 has aprolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc Natl Acad Sci USA 95:14733-14738
16. Bartels ED, Lauritsen M, Nielsen LB 2002 Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51:1233-1239
17. Nakae J, Kitamura T, Kitamura Y, Biggs 3rd WH, Arden KC, Accili D 2003 The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119-129
18. Naïmi M, Gautier N, Chaussade C, Valverde AM, Accili D, Van Obberghen E 2007 Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinology 148:2424-2434
19. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S 2009 Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
20. Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR 1997 Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454-462
21. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS 2008 Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8:512-521
22. Brown MS, Goldstein JL 2008 Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95-96
23. Woodside WF, Heimberg M 1976 Effects of anti-insulin serum, insulin, and glucose on output of triglycerides and on ketogenesis by the perfused rat liver. J Biol Chem 251:13-23
24. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferré P 1994 Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 8:36-42 (Pubitemid 24047409)
25. Semenkovich CF, Coleman T, Goforth R 1993 Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stability. J Biol Chem 268:6961-6970 (Pubitemid 23105579)
26. Brown AM, Wiggins D, Gibbons GF 1999 Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich ApoB-containing lipoproteins in primary hepatocyte cultures. Arterioscler Thromb Vasc Biol 19:321-329 (Pubitemid 29072746)
27. Durrington PN, Newton RS, Weinstein DB, Steinberg D 1982 Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 70:63-73 (Pubitemid 12090826)
28. Mittendorfer B, Patterson BW, Klein S, Sidossis LS 2003 VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab 284:E708-E715 (Pubitemid 36323863)
29. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR 1998 Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 275:E798-E805
30. Aarsland A, Chinkes D, Wolfe RR 1996 Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest 98:2008-2017 (Pubitemid 26376288)
31. Zhande R, Zhang W, Zheng Y, Pendleton E, Li Y, Polakiewicz RD, Sun XJ 2006 Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2. J Biol Chem 281:39071-39080 (Pubitemid 46041866)
32. Zhande R, Mitchell JJ, Wu J, Sun XJ 2002 Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 22:1016-1026 (Pubitemid 34094839)
33. Sidossis LS, Mittendorfer B, Walser E, Wolfe RR 1999 Regional disposal of intravenously infused glucose during prolonged hyperglycemia-hyperinsulinemia. J Nutr Biochem 10:547-554 (Pubitemid 29440842)
34. Wolfe RR, Shaw JH, Durkot MJ 1985 Effect of sepsis on VLDL kinetics: responses in basal state and during glucose infusion. Am J Physiol 248:E732-E740
35. Nakae J, Kitamura T, Silver DL, Accili D 2001 The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359-1367 (Pubitemid 33107764)
36. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N, Perrey S, Iizuka Y, Tamura Y, Amemiya-Kudo M, Yoshikawa T, Okazaki H, Ohashi K, Harada K, Matsuzaka T, Sone H, Gotoda T, Nagai R, Ishibashi S, Yamada N 2001 Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276:37402-37408
37. Fujimoto Y, Donahue EP, Shiota M 2004 Defect in glucokinase translocation in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 287:E414-E423
38. Fujimoto Y, Torres TP, Donahue EP, Shiota M 2006 Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 55:2479-2490 (Pubitemid 44871148)
39. Chan TM, Exton JH 1976 A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71:96-105
40. Bligh EG, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
41. DeBodo RC, Steele R, Altszuler N, Dunn A, Bishop JS 1963 On the hormonal regulation of carbohydrate metabolism. Recent Prog Horm Res 19:445-488
42. Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD 2008 Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes 57:1482-1490
43. Davies MN, O'Callaghan BL, Towle HC 2008 Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J Biol Chem 283:24029-24038
44. Ma L, Tsatsos NG, Towle HC 2005 Direct role of ChREBP. Mlx in regulating hepatic glucose-responsive genes. J Biol Chem 280:12019-12027
45. Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J, Postic C 2008 ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 118:956-964 (Pubitemid 351364603)
46. Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT, Depinho RA, Puigserver P, White MF 2009 Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 15:1307-1311
47. Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR 2008 Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 7:125-134
48. Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P, Soos MA, Carpenter TA, Lomas DJ, Cochran EK, Gorden P, O'Rahilly S, Savage DB 2009 Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119:315-322